carbostyril has been researched along with Lacrimal Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, S; Nakamura, T; Nakayama, T; Sotozono, C; Tanaka, H; Tsukamoto, M; Watanabe, A; Yokoi, N | 1 |
| Ikeda, T; Mimura, M; Oku, H; Sato, B; Ueki, M | 1 |
2 other study(ies) available for carbostyril and Lacrimal Duct Obstruction
| Article | Year |
|---|---|
Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function.
Topics: Alanine; Animals; Anti-Ulcer Agents; Cell Survival; Cells, Cultured; Disease Models, Animal; Electric Impedance; Epithelial Cells; Interleukin-6; Lacrimal Apparatus; Lacrimal Duct Obstruction; Male; Microscopy, Electron, Scanning; Protective Agents; Quinolones; Rabbits | 2020 |
Effect of rebamipide ophthalmic suspension on the success of lacrimal stent intubation.
Topics: Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Female; Humans; Intubation; Lacrimal Duct Obstruction; Male; Middle Aged; Nasolacrimal Duct; Ophthalmic Solutions; Postoperative Care; Prognosis; Quinolones; Stents; Suspensions | 2016 |